Massachusetts General Hospital: Skin Neoplasms trials

The registry lists 11 Skin Neoplasms studies with Massachusetts General Hospital as lead sponsor. 1 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 1Phase 2 5No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cryoablation+Ipilimumab+Nivolumab in MelanomaRecruitingNCT05779423Phase 2
• Correlation Between Skin Carotenoid Levels and Previous History of Skin CancerCompletedNCT00836342Results posted
• Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen UseCompletedNCT00535769Early Phase 1Results posted
• Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant RecipientsWithdrawnNCT04642287Phase 2
• Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant RecipientsWithdrawnNCT04329221Phase 2
• Infliximab for Treatment of Immune Checkpoint Inhibitor ColitisActive, not recruitingNCT04305145Phase 2
• Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to SchwannomatosisActive, not recruitingNCT04163419Phase 2
• Chemical Peels and Fractional Laser on IGF-1 Levels in SkinStatus unknownNCT03775031Not applicable
• A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its PrecursorsWithdrawnNCT02813902Phase 1
• Optical Imaging for Preoperative Delineation of Nonmelanoma Skin CancersStatus unknownNCT02666833
• Optical Frequency Domain Imaging for Non-melanoma Skin CancersCompletedNCT01662713Not applicable